Echinocandins for candidemia in adults without neutropenia

被引:76
作者
Bennett, John E. [1 ]
机构
[1] NIAID, Clin Mycol Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1056/NEJMct060052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 62-year-old man was admitted to the intensive care unit (ICU) with severe community-acquired pneumonia. On the sixth hospital day, he remained intubated and was receiving broad-spectrum antibiotics for his pneumonia when an episode of hypotension occurred, requiring volume expansion and the administration of vasopressors. The patient had diffuse pulmonary infiltrates and a serum creatinine level of 3 mg per deciliter (265 μmol per liter) and required mechanical ventilation with an oxygen concentration of 50%. Three days later, a blood culture of a specimen obtained from his venous catheter was reported to be growing candida species other than Candida albicans. An infectious disease consultant recommended that the central venous catheter be removed and replaced in another site and that treatment with caspofungin be initiated. Copyright © 2006 Massachusetts Medical Society.
引用
收藏
页码:1154 / 1159
页数:6
相关论文
共 33 条
  • [1] Treatment of fungal infections in hematology and oncology -: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
    Böhme, A
    Ruhnke, M
    Buchheidt, D
    Karthaus, M
    Einsele, H
    Guth, S
    Heussel, G
    Heussel, CP
    Junghanss, C
    Kern, WK
    Kubin, T
    Maschmeyer, G
    Sezer, O
    Silling, G
    Südhoff, T
    Szelényi, H
    Ullmann, AJ
    [J]. ANNALS OF HEMATOLOGY, 2003, 82 (Suppl 2) : S133 - S140
  • [2] Biofilm formation by the fungal pathogen Candida albicans:: Development, architecture, and drug resistance
    Chandra, J
    Kuhn, DM
    Mukherjee, PK
    Hoyer, LL
    McCormick, T
    Ghannoum, MA
    [J]. JOURNAL OF BACTERIOLOGY, 2001, 183 (18) : 5385 - 5394
  • [3] Fungal biofilms and antimycotics
    Chandra, J
    Zhou, GY
    Ghannoum, MA
    [J]. CURRENT DRUG TARGETS, 2005, 6 (08) : 887 - 894
  • [4] Micafungin: A new echinocandin
    Chandrasekar, PH
    Sobel, JD
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 42 (08) : 1171 - 1178
  • [5] Global distribution and outcomes for Candida species causing invasive candidiasis:: Results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis
    Colombo, AL
    Perfect, J
    DiNubile, M
    Bartizal, K
    Motyl, M
    Hicks, P
    Lupinacci, R
    Sable, C
    Kartsonis, N
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (08) : 470 - 474
  • [6] Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B
    Cuenca-Estrella, M
    Mellado, E
    Díaz-Guerra, TM
    Monzón, A
    Rodríguez-Tudela, JL
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (03) : 475 - 477
  • [7] Echinocandin antifungal drugs
    Denning, DW
    [J]. LANCET, 2003, 362 (9390) : 1142 - 1151
  • [8] British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections
    Denning, DW
    Kibbler, CC
    Barnes, RA
    [J]. LANCET INFECTIOUS DISEASES, 2003, 3 (04) : 230 - 240
  • [9] Guidelines for the treatment of invasive fungal infection.: Invasive fungal infection by Candida spp.
    Gavaldà, J
    Ruiz, I
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2003, 21 (09): : 498 - 508
  • [10] GAVALDA J, 2004, ENFERM INFEC MICR CL, V22, P137